Tomomi Higashide Selected Research

Neovascular Glaucoma

11/2022	Comparing Surgical Outcomes in Neovascular Glaucoma between Tube and Trabeculectomy: A Multicenter Study.
1/2021	Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study.
1/2021	Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial.
1/2015	Long-Term Outcomes and Prognostic Factors of Trabeculectomy following Intraocular Bevacizumab Injection for Neovascular Glaucoma.
4/2012	Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.
1/2012	Cystoid macular edema associated with oral antineoplastic agent s-1 in a patient with diabetic retinopathy.
2/2010	Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomomi Higashide Research Topics

Disease

23	Glaucoma 11/2022 - 09/2007
9	Low Tension Glaucoma 12/2020 - 10/2008
8	Blister (Bulla) 07/2016 - 07/2005
7	Neovascular Glaucoma 11/2022 - 02/2010
6	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2022 - 02/2007
5	Retinal Detachment (Retinal Detachments) 01/2018 - 09/2007
4	Ganglion Cysts (Ganglion) 01/2020 - 08/2013
4	Myopia 01/2020 - 09/2007
3	Epiretinal Membrane (Epiretinal Membranes) 03/2021 - 01/2017
3	Retinal Perforations 01/2017 - 09/2007
3	Infections 07/2016 - 10/2012
3	Cataract (Cataracts) 11/2015 - 03/2008
3	Retinal Degeneration 03/2007 - 02/2002
2	Atrophy 01/2022 - 01/2019
2	Keratitis 01/2021 - 08/2002
2	Vision Disorders (Hemeralopia) 11/2018 - 01/2018
2	Ocular Hypertension (Glaucoma, Suspect) 04/2014 - 09/2011
2	Cone-Rod Dystrophies 03/2007 - 02/2002
1	Exfoliation Syndrome 01/2021
1	Eye Diseases (Eye Disease) 01/2020
1	Choroidal Effusions 01/2019
1	Corneal Endothelial Cell Loss 01/2019
1	Aniseikonia 11/2018
1	Inflammation (Inflammations) 01/2017
1	Cicatrix (Scar) 06/2015
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 05/2015
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2014
1	Retinal Artery Occlusion 04/2012
1	Myocardial Infarction 04/2012
1	Stroke (Strokes) 04/2012
1	Macular Edema 01/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2012
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2012
1	Hemorrhage 03/2011
1	Hypertension (High Blood Pressure) 06/2010
1	Uveitis 07/2009
1	Late-Onset Retinal Degeneration 03/2007
1	Retrograde Degeneration 03/2007

Drug/Important Bio-Agent (IBA)

14	Retinaldehyde (Retinal)IBA 01/2020 - 03/2007
5	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2022 - 10/2012
4	Bevacizumab (Avastin)FDA Link 01/2015 - 02/2010
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
3	Latanoprost (Xalatan)FDA Link 01/2017 - 09/2011
2	afliberceptIBA 01/2021 - 01/2021
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2016 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 03/2005
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2009 - 10/2008
2	LigandsIBA 12/2009 - 10/2008
2	Hyaluronic Acid (Hyaluronan)IBA 03/2008 - 07/2005
2	Mutant Proteins (Protein, Mutant)IBA 03/2007 - 02/2002
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Protein AggregatesIBA 01/2021
1	Carbonic Anhydrase InhibitorsIBA 01/2019
1	rebamipideIBA 01/2017
1	isopropyl unoprostone (Rescula)FDA Link 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Rose BengalIBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2017
1	Ophthalmic Solutions (Eye Drops)IBA 01/2017
1	MucinsIBA 03/2016
1	Silicone OilsIBA 01/2016
1	Dihydrotachysterol (AT 10)IBA 06/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2015
1	SteroidsIBA 05/2015
1	prostaglandin F2alpha receptorIBA 04/2014
1	hydroxide ionIBA 04/2014
1	ProstaglandinsIBA 04/2014
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Monoclonal AntibodiesIBA 04/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 09/2010
1	HLA-DQB1 antigen (HLA DQB1)IBA 09/2010
1	Hemoglobins (Hemoglobin)IBA 06/2010
1	CreatinineIBA 06/2010
1	Toll-Like Receptor 2IBA 12/2009
1	LipopolysaccharidesIBA 07/2009
1	EndotoxinsIBA 07/2009
1	Toll-Like Receptor 4IBA 10/2008
1	4-O-carboxymethylascochlorinIBA 03/2007

Therapy/Procedure

15	Trabeculectomy (Trabeculoplasty) 11/2022 - 07/2005
8	Lasers (Laser) 01/2022 - 09/2007
7	Vitrectomy 03/2021 - 09/2007
6	Therapeutics 01/2020 - 07/2003
4	Filtering Surgery 06/2015 - 09/2007
1	Contact Lenses 12/2020
1	Iridectomy 03/2016
1	Percutaneous Collagen Induction 11/2015
1	Phacoemulsification 11/2015
1	Scleral Buckling 11/2012
1	Injections 04/2012
1	Intraocular Injections 04/2012
1	Gastrectomy 01/2012
1	Intravitreal Injections 01/2012
1	Light Coagulation 01/2012
1	Vitreoretinal Surgery 03/2008
1	Slit Lamp 09/2007
1	Laser Therapy (Surgery, Laser) 02/2007